Stock listing

MRNA Stock Price, News, Filings & Events — Moderna, Inc.

Selected listing: MRNA · NASDAQ · USD · US

MRNA:NASDAQ is the primary listing for Moderna, Inc., a biotechnology company focused on mRNA-based vaccines and therapies. With a market capitalization of around $24.5 billion, Moderna is recognized for its significant contributions to the healthcare sector, especially in response to global health challenges. The company continues to be a key player in vaccine development and is actively involved in various research initiatives and clinical trials. Recent news and filings highlight its ongoing projects and advancements in mRNA technology.

MRNA:NASDAQUSDUSUpdated July 21, 2026
Moderna, Inc. logo
Ticker
MRNA:NASDAQ
Asset type
Stock
Market cap
$24.53B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Moderna, Inc. MRNA:NASDAQ stock context

MRNA:NASDAQ is the primary listing for Moderna, Inc., a biotechnology company focused on mRNA-based vaccines and therapies. With a market capitalization of around $24.5 billion, Moderna is recognized for its significant contributions to the healthcare sector, especially in response to global health challenges. The company continues to be a key player in vaccine development and is actively involved in various research initiatives and clinical trials. Recent news and filings highlight its ongoing projects and advancements in mRNA technology.

Research Moderna, Inc.

Alternate listings